These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 8994122)

  • 1. High resolution proton MR spectroscopy of cerebrospinal fluid in MS patients. Comparison with biochemical changes in demyelinating plaques.
    Simone IL; Federico F; Trojano M; Tortorella C; Liguori M; Giannini P; Picciola E; Natile G; Livrea P
    J Neurol Sci; 1996 Dec; 144(1-2):182-90. PubMed ID: 8994122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Axonal damage in multiple sclerosis plaques: a combined magnetic resonance imaging and 1H-magnetic resonance spectroscopy study.
    Simone IL; Tortorella C; Federico F; Liguori M; Lucivero V; Giannini P; Carrara D; Bellacosa A; Livrea P
    J Neurol Sci; 2001 Jan; 182(2):143-50. PubMed ID: 11137520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multiparametric data analysis showing the potential of localized proton MR spectroscopy of the brain in the metabolic characterization of neurological diseases.
    Confort-Gouny S; Vion-Dury J; Nicoli F; Dano P; Donnet A; Grazziani N; Gastaut JL; Grisoli F; Cozzone PJ
    J Neurol Sci; 1993 Sep; 118(2):123-33. PubMed ID: 8229060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble intercellular adhesion molecule-1 in serum and cerebrospinal fluid of clinically active relapsing-remitting multiple sclerosis: correlation with Gd-DTPA magnetic resonance imaging-enhancement and cerebrospinal fluid findings.
    Trojano M; Avolio C; Simone IL; Defazio G; Manzari C; De Robertis F; Calò A; Livrea P
    Neurology; 1996 Dec; 47(6):1535-41. PubMed ID: 8960741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrospinal Fluid Dynamics in Patients with Multiple Sclerosis: The Role of Phase-Contrast MRI in the Differential Diagnosis of Active and Chronic Disease.
    Öner S; Kahraman AS; Özcan C; Özdemir ZM; Ünlü S; Kamışlı Ö; Öner Z
    Korean J Radiol; 2018; 19(1):72-78. PubMed ID: 29354002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory multiple-sclerosis plaques generate characteristic metabolic profiles in cerebrospinal fluid.
    Lutz NW; Viola A; Malikova I; Confort-Gouny S; Audoin B; Ranjeva JP; Pelletier J; Cozzone PJ
    PLoS One; 2007 Jul; 2(7):e595. PubMed ID: 17611627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrospinal fluid metabolic profiles in multiple sclerosis and degenerative dementias obtained by high resolution proton magnetic resonance spectroscopy.
    Nicoli F; Vion-Dury J; Confort-Gouny S; Maillet S; Gastaut JL; Cozzone PJ
    C R Acad Sci III; 1996 Jul; 319(7):623-31. PubMed ID: 9011324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear magnetic resonance study of cerebrospinal fluid from patients with multiple sclerosis.
    Lynch J; Peeling J; Auty A; Sutherland GR
    Can J Neurol Sci; 1993 Aug; 20(3):194-8. PubMed ID: 8221382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetic resonance spectroscopy of memory and frontal brain region in early multiple sclerosis.
    Staffen W; Zauner H; Mair A; Kutzelnigg A; Kapeller P; Stangl H; Raffer E; Niederhofer H; Ladurner G
    J Neuropsychiatry Clin Neurosci; 2005; 17(3):357-63. PubMed ID: 16179658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proton magnetic resonance spectroscopy for metabolic characterization of plaques in multiple sclerosis.
    Matthews PM; Francis G; Antel J; Arnold DL
    Neurology; 1991 Aug; 41(8):1251-6. PubMed ID: 1650931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolite abnormalities in progressive multifocal leukoencephalopathy by proton magnetic resonance spectroscopy.
    Chang L; Ernst T; Tornatore C; Aronow H; Melchor R; Walot I; Singer E; Cornford M
    Neurology; 1997 Apr; 48(4):836-45. PubMed ID: 9109865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolomic profiling of CSF in multiple sclerosis and neuromyelitis optica spectrum disorder by nuclear magnetic resonance.
    Kim HH; Jeong IH; Hyun JS; Kong BS; Kim HJ; Park SJ
    PLoS One; 2017; 12(7):e0181758. PubMed ID: 28746356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The contribution of (1)H-magnetic resonance spectroscopy in defining the pathophysiology of multiple sclerosis.
    Simone IL; Tortorella C; Federico F
    Ital J Neurol Sci; 1999; 20(5 Suppl):S241-5. PubMed ID: 10662956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proton MR spectroscopy and MR imaging in acute and chronic multiple sclerosis--ringlike appearances in acute plaques.
    Landtblom AM; Sjöqvist L; Söderfeldt B; Nyland H; Thuomas KA
    Acta Radiol; 1996 May; 37(3 Pt 1):278-87. PubMed ID: 8845254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specificity and correlation with disease activity of cerebrospinal fluid osteopontin levels in patients with multiple sclerosis.
    Chowdhury SA; Lin J; Sadiq SA
    Arch Neurol; 2008 Feb; 65(2):232-5. PubMed ID: 18268193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conventional and advanced magnetic resonance imaging in tumefactive demyelination.
    Saini J; Chatterjee S; Thomas B; Kesavadas C
    Acta Radiol; 2011 Dec; 52(10):1159-68. PubMed ID: 22025739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebrospinal fluid lactate and glutamine are reduced in multiple sclerosis.
    Aasly J; Gårseth M; Sonnewald U; Zwart JA; White LR; Unsgård G
    Acta Neurol Scand; 1997 Jan; 95(1):9-12. PubMed ID: 9048978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proton magnetic resonance spectroscopy of cerebrospinal fluid as an aid in neurological diagnosis.
    Hiraoka A; Miura I; Hattori M; Tominaga I; Kushida K; Maeda M
    Biol Pharm Bull; 1994 Jan; 17(1):1-4. PubMed ID: 8148794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrospinal fluid molecular demonstration of Chlamydia pneumoniae DNA is associated to clinical and brain magnetic resonance imaging activity in a subset of patients with relapsing-remitting multiple sclerosis.
    Contini C; Cultrera R; Seraceni S; Castellazzi M; Granieri E; Fainardi E
    Mult Scler; 2004 Aug; 10(4):360-9. PubMed ID: 15327030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrathecal synthesis of soluble HLA-G and HLA-I molecules are reciprocally associated to clinical and MRI activity in patients with multiple sclerosis.
    Fainardi E; Rizzo R; Melchiorri L; Castellazzi M; Paolino E; Tola MR; Granieri E; Baricordi OR
    Mult Scler; 2006 Feb; 12(1):2-12. PubMed ID: 16459714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.